In a preclinical study, Molinolo et al. demonstrated that mTOR pathway activation was shown in most human papillomavirus-positive head and neck squamous cell carcinoma and cervical cancer squamous cell carcinoma tumor xenografts. The gene discussed is MTOR; the disease is neoplasm.